Suchergebnisse - "Kamimura, Hidetaka"

PubPharm (113)

81

Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver

enthalten in: Pharmaceutical research | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

82

Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver

enthalten in: Pharmaceutical research | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

83

Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats

enthalten in: European journal of drug metabolism and pharmacokinetics | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

84

The canine CYP1A2 deficiency polymorphism dramatically affects the pharmacokinetics of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-D]-pyrimidine-2-(1H)-one (YM-64227), a phosphodiesterase type 4 inhibitor

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2006

von Tenmizu, D. | Noguchi, K. | Kamimura, H. | +2

85

Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats

enthalten in: European journal of drug metabolism and pharmacokinetics | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

86

In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid

enthalten in: Biopharmaceutics & drug disposition | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

87

In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9-potent inhibition by niflumic acid

enthalten in: Biopharmaceutics & drug disposition | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

88

In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans

enthalten in: Biopharmaceutics & drug disposition | 2006

von Mano, Y. | Usui, T. | Kamimura, H.

89

THE CANINE CYP1A2 DEFICIENCY POLYMORPHISM DRAMATICALLY AFFECTS THE PHARMACOKINETICS OF 4-CYCLOHEXYL-1-ETHYL-7-METHYLPYRIDO[2,3-D]-PYRIMIDINE-2-(1H- )-ONE (YM-64227), A PHOSPHODIESTERASE TYPE 4 INHIBITOR

enthalten in: Drug metabolism and disposition | 2006

von Tenmizu, D. | Noguchi, K. | Kamimura, H. | +2

90

Simultaneous determination of YM928, a novel noncompetitive AMPA receptor antagonist, and its demethylated metabolite in rat, dog and monkey plasma by high-performance liquid chromatography with ultraviolet detection

enthalten in: Biomedical chromatography | 2006

von Kato, K. | Noguchi, K. | Aoki, T. | +2